0001104659-17-074113.txt : 20171219 0001104659-17-074113.hdr.sgml : 20171219 20171219182537 ACCESSION NUMBER: 0001104659-17-074113 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20171215 FILED AS OF DATE: 20171219 DATE AS OF CHANGE: 20171219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luo Mary Z. CENTRAL INDEX KEY: 0001611156 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 171265227 MAIL ADDRESS: STREET 1: 11570 6TH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhang Jack Y. CENTRAL INDEX KEY: 0001611157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 171265228 MAIL ADDRESS: STREET 1: 11570 6TH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001297184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330702205 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 909-980-9484 MAIL ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 4 1 a4.xml 4 X0306 4 2017-12-15 0 0001297184 Amphastar Pharmaceuticals, Inc. AMPH 0001611157 Zhang Jack Y. C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730 1 1 1 0 CEO & Chief Scientific Officer 0001611156 Luo Mary Z. C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730 1 1 1 0 COO, Chief Scientist/Chairman Common Stock 2017-12-15 4 M 0 639584 12.023 A 2537431 D Common Stock 2017-12-15 4 F 0 524266 19.30 D 2013165 D Common Stock 2017-12-15 4 M 0 373091 12.023 A 1636469 I See footnote Common Stock 2017-12-15 4 F 0 305823 19.30 D 1330646 I See footnote Common Stock 7461594 I See footnote Common Stock 5000 I See footnote Common Stock 200000 I See footnote Employee Stock Option (right to buy) 12.023 2017-12-15 4 M 0 639584 0 D 2018-07-05 Common Stock 639584 319791 D Employee Stock Option (right to buy) 12.023 2017-12-15 4 M 0 373091 0 D 2018-07-05 Common Stock 373091 186545 I See footnote The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife. The shares are held of record by APCL, of which the reporting persons are the sole owners. The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose. The shares are held of record by a trust for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose. Shares subject to the option are fully vested and immediately exercisable. Exhibit 24.1 - Zhang Power of Attorney; Exhibit 24.2 - Luo Power of Attorney /s/ Ken Stupak, by power of attorney for Jack Y. Zhang 2017-12-18 /s/ Ken Stupak, by power of attorney for Mary Z. Luo 2017-12-18 EX-24.1 2 ex-24d1.htm EX-24.1

Exhibit 24.1

POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of Amphastar Pharmaceuticals, Inc., (the “Company”), hereby constitutes and appoints Jason Shandell, William Peters, Eva Wen and Ken Stupak, and each of them, as the undersigned’s true and lawful attorney-in-fact to:

1. prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain EDGAR codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

2. complete and execute Forms 4 and 5 and other forms and all amendments thereto as such attorney-in-fact shall in his discretion determine to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned’s ownership, acquisition or disposition of securities of the Company; and

3. do all acts necessary in order to file such forms with the SEC, any securities exchange or national association, the Company and such other person or agency as the attorneys-in-fact shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 (as amended).

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 20th day of November, 2017.

	Signature:	/s/ Jack Yongfeng Zhang

	Print Name:	Jack Yongfeng Zhang

EX-24.2 3 ex-24d2.htm EX-24.2

Exhibit 24.2

POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of Amphastar Pharmaceuticals, Inc., (the “Company”), hereby constitutes and appoints Jason Shandell, William Peters, Eva Wen and Ken Stupak, and each of them, as the undersigned’s true and lawful attorney-in-fact to:

1. prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain EDGAR codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

2. complete and execute Forms 4 and 5 and other forms and all amendments thereto as such attorney-in-fact shall in his discretion determine to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned’s ownership, acquisition or disposition of securities of the Company; and

3. do all acts necessary in order to file such forms with the SEC, any securities exchange or national association, the Company and such other person or agency as the attorneys-in-fact shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 (as amended).

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 7th day of November, 2017.

	Signature:	/s/ Mary Ziping Luo

	Print Name:	Mary Ziping Luo